AU2014233362A1 - Topical compositions of flunisolide and methods of treatment - Google Patents

Topical compositions of flunisolide and methods of treatment Download PDF

Info

Publication number
AU2014233362A1
AU2014233362A1 AU2014233362A AU2014233362A AU2014233362A1 AU 2014233362 A1 AU2014233362 A1 AU 2014233362A1 AU 2014233362 A AU2014233362 A AU 2014233362A AU 2014233362 A AU2014233362 A AU 2014233362A AU 2014233362 A1 AU2014233362 A1 AU 2014233362A1
Authority
AU
Australia
Prior art keywords
flunisolide
composition
topical
skin
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014233362A
Other languages
English (en)
Inventor
Douglas Anthony Bakan
Tushar Deoram Jadhav
Mukesh Kumar
Amol Subhash Mandhare
Steven B. Newhard
Nilendu Sen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicis Pharmaceutical Corp
Original Assignee
Medicis Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicis Pharmaceutical Corp filed Critical Medicis Pharmaceutical Corp
Publication of AU2014233362A1 publication Critical patent/AU2014233362A1/en
Priority to AU2019200064A priority Critical patent/AU2019200064A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2014233362A 2013-03-15 2014-03-14 Topical compositions of flunisolide and methods of treatment Abandoned AU2014233362A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2019200064A AU2019200064A1 (en) 2013-03-15 2019-01-07 Topical compositions of flunisolide and methods of treatment

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN303/KOL/2013 2013-03-15
IN303KO2013 2013-03-15
PCT/US2014/029722 WO2014145067A1 (en) 2013-03-15 2014-03-14 Topical compositions of flunisolide and methods of treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019200064A Division AU2019200064A1 (en) 2013-03-15 2019-01-07 Topical compositions of flunisolide and methods of treatment

Publications (1)

Publication Number Publication Date
AU2014233362A1 true AU2014233362A1 (en) 2015-10-01

Family

ID=54249680

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2014233362A Abandoned AU2014233362A1 (en) 2013-03-15 2014-03-14 Topical compositions of flunisolide and methods of treatment
AU2019200064A Abandoned AU2019200064A1 (en) 2013-03-15 2019-01-07 Topical compositions of flunisolide and methods of treatment

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2019200064A Abandoned AU2019200064A1 (en) 2013-03-15 2019-01-07 Topical compositions of flunisolide and methods of treatment

Country Status (7)

Country Link
US (1) US10953021B2 (enExample)
EP (1) EP2968572A1 (enExample)
JP (1) JP6473134B2 (enExample)
CN (1) CN105188758A (enExample)
AU (2) AU2014233362A1 (enExample)
CA (1) CA2905587A1 (enExample)
WO (1) WO2014145067A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
WO2011026076A2 (en) 2009-08-31 2011-03-03 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20110268761A1 (en) 2010-03-02 2011-11-03 Hapten Pharmaceuticals, Llc Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
EA201691808A8 (ru) * 2014-03-11 2017-04-28 Промиус Фарма, Ллк Кортикостероидные композиции для местного применения
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2016026527A1 (en) * 2014-08-20 2016-02-25 Amantin Experts Compositions and methods for controlled moisturizing and release of active ingredients
CA2997949A1 (en) * 2015-09-11 2017-03-16 Rxi Pharmaceuticals Corporation Methods for treating skin disorders and conditions utilizing haptens
WO2018101443A1 (ja) * 2016-12-01 2018-06-07 マルホ株式会社 医療用皮膚外用剤
CN108938674A (zh) * 2017-05-27 2018-12-07 福建省山河药业有限公司 红色诺卡氏菌细胞壁骨架在制备治疗皮肤病变药物中的用途
JP7324210B2 (ja) * 2018-01-31 2023-08-09 ティダブリューアイ・バイオテクノロジー・インコーポレイテッド トファシチニブを含む局所製剤
US10653656B2 (en) 2018-04-05 2020-05-19 Bausch Health Ireland Limited Topical pharmaceutical compositions for treating skin conditions
EP3586849A1 (en) * 2018-06-29 2020-01-01 Aprofol AG Folate preparations
MX368750B (es) * 2018-08-31 2019-10-15 Cell Therapy And Tech S A De C V Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular.
AU2019403117B2 (en) 2018-12-18 2023-05-25 The Procter & Gamble Company Personal care composition with increased vapor release
AU2022346789A1 (en) * 2021-09-15 2024-03-28 Ocusoft, Inc. Ointments for treating dry skin
CN119997936A (zh) * 2022-12-15 2025-05-13 科笛生物医药(无锡)有限公司 羟基二苯乙烷类化合物软膏及其用途和制备方法
CN120500342A (zh) * 2022-12-20 2025-08-15 格林尼卡皮肤股份公司 用于局部皮肤治疗的新的组合物
WO2025182623A1 (ja) * 2024-02-28 2025-09-04 テクノガード株式会社 水および油難溶性薬物含有乳剤およびその製造方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) 1964-03-24 Chioacyl
US4933168A (en) 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
JPS56135416A (en) * 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
GB8420771D0 (en) 1984-08-15 1984-09-19 Efamol Ltd Treatment of skin disorders
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
IT1256061B (it) 1992-11-20 1995-11-23 Composizione terapeutica per uso rettale a base di flunisolide e/o deirelativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
US5840277A (en) 1993-03-30 1998-11-24 Charlotte Hospital Authority Treatment of chronic pulmonary inflammation
US7887842B2 (en) * 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20060045850A1 (en) * 2004-08-30 2006-03-02 Qpharma, Llc Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
WO2006102004A2 (en) * 2005-03-16 2006-09-28 Taro Pharmaceuticals U.S.A., Inc. A stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
WO2009100406A2 (en) * 2008-02-07 2009-08-13 Synta Pharmaceuticals Corp. Topical formulations for the treatment of psoriasis
WO2011156030A2 (en) * 2010-06-11 2011-12-15 Precision Dermatology, Inc. High oil-content emollient aerosol foam compositions

Also Published As

Publication number Publication date
CA2905587A1 (en) 2014-09-18
JP2016515525A (ja) 2016-05-30
CN105188758A (zh) 2015-12-23
US10953021B2 (en) 2021-03-23
JP6473134B2 (ja) 2019-02-20
WO2014145067A1 (en) 2014-09-18
US20140274982A1 (en) 2014-09-18
AU2019200064A1 (en) 2019-01-24
EP2968572A1 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
US10953021B2 (en) Topical compositions of flunisolide and methods of treatment
US8835410B2 (en) Treatment of eyelid dermatitis
US6238683B1 (en) Anhydrous topical skin preparations
US8735393B2 (en) Anhydrous topical skin preparations
US20130267490A1 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
KR102568036B1 (ko) 염증성 피부 질환 및 피부 병변을 치료하기 위한 산소첨가된 콜레스테롤 술페이트 (ocs) 의 용도
KR20200051854A (ko) 코르티코스테로이드를 포함하는 국소용 조성물
US20140154338A1 (en) Skin cream
US12491192B2 (en) Compositions and methods for the topical administration of spironolactone for the treatment of cutaneous signs of excess androgen and chronic stress response
US20200085902A1 (en) Composition and method for treating itching, burning and discomfort of the skin
KR20150128952A (ko) 플루니솔리드의 국소 조성물 및 치료 방법
US12280031B2 (en) Teriflunomide topical pharmaceutical compositions
CN118662507A (zh) 一种改善黄褐斑的外用组合物
EP1159956A2 (en) Anhydrous topical skin preparations
WO2018191601A1 (en) Stable pharmaceutical compositions comprising desonide
US20080027026A1 (en) Composition for the treatment of inflammatory conditions

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted